Literature DB >> 29445672

Catastrophic health expenditure among households with members with special diseases: A case study in Kurdistan.

Ghobad Moradi1, Hossein Safari2, Bakhtiar Piroozi1, Laila Qanbari3, Salahadin Farshadi4, Homan Qasri5, Fariba Farhadifar1.   

Abstract

Background: One of the main goals of health systems is to protect people against financial risks associated with diseases that can be catastrophic for patients. In 2014, Health Sector Evolution Plan (HSEP) was implemented in Iran; one of the objectives of HSEP was to reduce out-of-pocket payments and provide more financial protection for people. Therefore, the present study aimed at exploring the likelihood of facing catastrophic health expenditures (CHE) among households with members suffering from dialysis, kidney transplant, or multiple sclerosis (MS) after the implementation of HSEP.
Methods: A total number of 385 households were selected using stratified random sampling and were asked to complete the World Health Survey questionnaire through telephone conversations. As outlined by the World Health Organization (WHO), when household out-of-pocket expense for health services is ≥40% of its capacity to pay, then that household is considered to be facing CHE. Furthermore, determinants of CHE were identified using logistic regression.
Results: The percentage of facing catastrophic health care expenditures for households with a MS, dialysis, and kidney transplant patient was 20.6%, 18.7%, and 13.8%, respectively. Results of logistic regression analysis revealed that patient's economic status, level of education, supplementary insurance status, type of disease, multiple members with special diseases in the household, rural residence, use of inpatient, dental, and rehabilitation services were effective factors for determining the likelihood of facing CHE.
Conclusion: Despite the implementation of HSEP, the percentage of CHE is still high for households that have members who suffer from special diseases. However, basic health insurance packages should be amended and more cost-sharing exemptions should be granted to provide more financial protection for the vulnerable households.

Entities:  

Keywords:  Catastrophic Health Expenditures; Dialysis; Health Expenditures; Health System Reform; Kidney Transplant; Multiple Sclerosis (MS)

Year:  2017        PMID: 29445672      PMCID: PMC5804459          DOI: 10.14196/mjiri.31.43

Source DB:  PubMed          Journal:  Med J Islam Repub Iran        ISSN: 1016-1430


↑ What is “already known” in this topic:

In Iran, no study has ever been conducted to measure the exposure of households with members suffering from special diseases with catastrophic health expenditure.

→ What this article adds:

In Kurdistan province, the percentage of facing catastrophic health care expenditures for households with a multiple sclerosis, dialysis, and kidney transplant patient was 20.6%, 18.7%, and 13.8%, respectively.

Introduction

One of the most important dimensions of universal health coverage (UHC), which has received the most attention, is the financial protection of people at the time of paying for health services. In 2005, all members of WHO aimed to develop a health financing system through which people would not face any problem at the time of paying for health services. This goal was later called universal health coverage (UHC) (1). Removing financial barriers that exist in the heart of out-of-pocket payment system helps the poor to access health care services (2). According to the WHO report in 2011, the share of private expenditures from total health expenditures has varied from 0.1% to 84.1% among countries worldwide, most of the costs in the form of out-of-pocket. The average of this share for countries of East Mediterranean region was 49% in the same year (3). Out-of-pocket payment at the time of receiving health services can cause CHE. These costs occur when household health expenditures are equal to or more than 40% of their residual income after meeting their basic needs (4). As reported by WHO in 2005, annually, 44 million households around the world face CHE (5). Moreover, according to a study conducted in Sanandaj, Iran, 4.8% of the households had faced CHE in 2015 (6). This percentage was 67.9 for households with cancer patients in Iran in 2014 (7). Households with disabled members or with members suffering from chronic diseases are more likely to face CHE (8-10). According to a report released by Multiple Sclerosis International Federation, 2.3 million suffer from MS around the world (11). Moreover, 400000 people suffer from MS in the United States, and 10000 new patients are added to this number annually. The annual cost of this disease is over $9 billion in the U.S (11,12). As reported by WHO Collaborating Center on Donation and Transplantation, at least 79 950 kidney transplants were done in 2014 worldwide (13). In 2013, 17600 kidney transplants were performed in the United States and the kidney transplant waiting lists had 86965 candidates (14). Moreover, the total health care spending on end-stage renal disease was $ 32.9 billion in the US in 2010 (15). In Australia, the number of people who used renal replacement therapy raised from 6643 to 18 267 cases between 1991 to 2009 (16). Furthermore, in India, the incidence of end-stage renal disease has been estimated 226 per million population (9). In addition, according to the United Network for Organ Sharing (UNOS), the first-year billed charges for a kidney transplant are more than $262000 (17). In England, chronic kidney disease imposes £1.44 to £1.45 billion on its health system, which is equal to 13% of the total national health system expenditures. In addition, dialysis and renal replacement therapy count for 35% and more than 50% of these expenditures, respectively (10). The prevalence of MS is 15 to 30 per 100000 in Iran. According to a national study in Iran in 2011, the mean of total annual direct and indirect expenditure per MS patient was estimated to be $US24475 (18). In 2015, 2700 renal replacement therapies were performed in Iran, and the number of dialysis patients was reported to be 27000 (19). Diseases such as hemophilia, thalassemia, dialysis, renal replacement therapy, and epilepsy are among the special diseases list in Iran (20-22). Special diseases increase the health expenditures, reduce productivity, and cause early retirement or disability among patients (9, 24, 25). Therefore, it seems that the households with a member suffering from a special disease are more likely to face CHE. The topic of financial protection of patients against health services expenditures has turned into a highly important issue in Iran. To reach this goal, a series of reforms under the name of “Health Sector Evolution Plan” with 3 approaches of financial protection of patients against health expenditures, improving access to health services, and enhancing the quality of health services have been started since April 30, 2014 (26). As outlined by WHO, increasing the share of health sector from general government budget is the first step to financially protect the population against health expenditures, especially for low and middle income countries (1). This issue has been taken into account in HSEP; in other words, besides the annual budget of the Ministry of Health and Medical Educations (MOHME), 10% of the revenues from targeted subsidy plan along with 1% value-added tax have been allocated to the health sector (6). Also, in Iran, universal coverage of health insurance is offered to the uninsured population in the form of HSEP and is free of charge. People with basic health insurance pay 3% to 6% of their total hospital bill for public hospitals (6,26). Studies show that implementation of health insurance plan in China, Thailand, and Mexico has reduced the likelihood of facing CHE. However, other studies illustrate that having health insurance does not necessarily protect households against CHE (27-31). Considering the special conditions of these patients, it seems that households with members suffering from special diseases are more likely to face CHE. Despite the importance of this issue, in Iran no study has ever been conducted to measure the exposure of such households with CHE. Thus, the present study aimed at determining the rate of exposure with CHE among households with patients suffering from special diseases including dialysis, kidney transplant, or MS in Kurdistan province after the implementation of HSEP. In addition, this study aimed at identifying the effective factors on these expenditures as well.

Methods

This descriptive-analytical study was conducted using cross-sectional data in Kurdistan province in 2015. Statistical community included all households of the province that had MS, dialysis, or kidney transplant patients among their family members. The number of these households in Kurdistan province in October 2015 was 719, 447, and 554 (this number refers to those patients who had kidney transplants in the previous year), respectively, with a p- value of = 0.5 (because no study has been done on the incidence of CHE among special patients in Iran), d = 0.05, and α= 0.05. Sample size was calculated to be 385 using the following formula: Sample size was selected randomly and proportionate to the number of households that had members suffering from M.S, dialysis, or kidney transplant. World Health Survey questionnaire was developed by WHO to evaluate the performance of health systems in 2003(31). This questionnaire consists of 2 sections: household and individual. The household section was used to gather data in this study. This section has been translated into Farsi and its validity and reliability were verified by Kavosi et al. (32). Data were collected through telephone conversations with the household head or the patients themselves if older than 18 years. Their contact numbers were provided by Special Diseases Center of Treatment Deputy for Kurdistan University of Medical Sciences. The recall period for total household expenditure, as well as the household health expenditure was 1 month (the last 30 days). On the other hand, this period was set on 1 month (30 last days) and 1 year for frequency of using outpatient and inpatient services, respectively. Households with health expenditures equal to or more than 40% of their capacity to pay were considered to be facing CHE. Moreover, household capacity to pay is the effective income of the household minus its subsistence expenditure. Meanwhile, household total expenditure was considered as a proxy for household effective income; this income has been considered in many countries as a better measure than the income reported in the household surveys that represents purchasing power. To calculate subsistence expenditure, food poverty line (meaning a part of total household expenditure which is spent on food costs) was used.Xu et al. has reported the methodological details on this subject (7,34). In addition, patient sex, household head sex, special disease of the household head, household size, patient level of education, marital status, and residence, type of patient basic and supplementary health insurance, type of patient special disease, frequency of using inpatient and outpatient services by the household, use of dentistry and rehabilitation services by the household, average total household expenditure, and average household health expenditure were entered into multiple logistic regression model as independent variables to determine the effective factors on the likelihood of facing CHE. Then, data were analyzed using backward method, with SPSS-20.

Ethical Considerations

The study was approved by the ethics committee of Kurdistan University of Medical Sciences, Sanandaj, Iran. Participation was voluntary in this study.

Results

The response rate of the households was 87%. Table 1 displays the demographic characteristics of the studied households. On average, 10.5% the total monthly household expenditure was spent for health services.
Table 1

Demographic characteristics of the studied population

VariablesMeanStandard Deviation
Monthly household expenditure (Exchange rate: 36 000 Iranian Rial to US$ 1.00)367.12 US$132.70 US$
Monthly Out-of-pocket health expenditure38.50 US$27.15 US$
Number of times household used inpatient services during the last year1.30.64
Number of times household used outpatient services during the last month1.60.72
Patient's age50.2 years10.12
Family size4.1 members1.15
All the studied households had basic health insurance. They had used outpatient and inpatient services at least once for the last month and year, respectively. The percentage of facing CHE for households with MS, dialysis, or kidney transplant patients was 20.6%, 18.7%, and 13.8%, respectively (Table 2).
Table 2

The Number and Percentage of Households Facing Catastrophic Health Expenditure by the Studied Variables, 2015

VariablesFaced with Catastrophic Health Expenditures
Yes (%)No (%)
Sex of the patientMale32 (21.2)119 (78.8)
Female29 (15.8)155 (84.2)
Sex of the household headMale53 (18.2)238 (81.8)
Female8 (18.2)36 (81.8)
Is household head the patient?Yes40 (21.3)148 (78.7
No21 (14.3)126 (85.7)
Household size1-27 (14.3)42 (85.7)
3-430 (20)120 (80)
>424 (17.6)112 (82.4)
Household’s economic status *First quintile (poorest)25 (25)81 (75)
Second quintile17 (20.7)65 (79.3)
Third quintile14 (18.9)60 (81.1)
Fourth quintile4 (8)46 (92)
Fifth quintile (richest)1 (4.3)22 (93.7)
level of educationIlliterate18 (23.1)60 (76.9)
Primary and Middle school23 (21.1)86 (78.9)
High school and Diploma9 (10)81 (90)
University11 (19)47 (81)
ResidenceUrban47 (20)188 (80)
Rural14 (14)86 (86)
Marital statusSingle3 (20)12 (80)
Married45 (18.1)203 (81.9)
Divorced7 (16.7)35 (83.3)
Widowed6 (20)24 (80)
Type of basic insuranceMedical services18 (13.1)119 (86.9)
Social security26 (23.4)85 (76.6)
Armed forces9 (17)44 (83)
Relief Committee4 (23.5)13 (76.5)
Others4 (23.5)13 (76.5)
Supplementary insurance statusYes3 (13.6)19 (86.4)
No58 (18.5)255 (81.5)
Type of diseaseDialysis12 (13.8)75 (86.2)
Multiple sclerosis29 (20.6)112 (79.4)
Kidney Transplantation20 (18.7)87 (81.3)
Multiple members with special disease in the householdYes5 (55.6)4 (44.4)
No56 (17.2)270 (82.8)
Use of dental servicesYes23 (28.8)57 (71.2)
No38 (14.9)217 (85.1)
Use of rehabilitation servicesYes13 (27.7)34 (72.3)
No48 (16.7)240 (83.3)

*Based on monthly total expenditure by the household

*Based on monthly total expenditure by the household

Effective Factors on Catastrophic Expenditures

Table 3 demonstrates the results of logistic regression. The most important factors were as follow: patient's education; household income; patient supplementary insurance status; type of special disease; a family member with a special disease; patient residence; frequency of using inpatient services; use of dental care; and use of rehabilitation services.
Table 3

Determinants of catastrophic health expenditures, 2015

Variables OR Confidence Interval (95%) p
HighestLowest
Level of education
Illiterate (Reference Category)1--
Primary and Middle school0.840.512.210.212
High school, Diploma and University0.461.242.610.012
Household’s economic status *
Fifth quintile (Reference Category)1--
Fourth quintile2.701.316.020.025
Third quintile4.383.029.920.029
Second quintile5.403.8112.910.036
First quintile (poorest)7.214.4115.450.041
Supplementary insurance status
Yes (Reference Category)1--
No 1.441.044.880.023
Type of disease
Dialysis (Reference Category) 1--
Multiple sclerosis2.101.384.220.020
Kidney Transplantation1.400.783.440.154
Family member with a special disease
1 member (Reference Category)1--
More than 1 member5.501.3319.110.048
Residence
Urban (Reference Category)1--
Rural1.900.834.610.118
Frequent use of inpatient services 1.701.112.390.011
Use of dental care
No (Reference Category)1--
Yes 2.341.514.760.036
Use of rehabilitation services
No (Reference Category)1--
Yes 2.331.465.770.042
Constant0.020.0070.0160.031
-2LL = 461.336a; Cox & Snell R square = 0.151; Nagelkerke R square= 0.261

*Based on monthly total expenditure by the household

*Based on monthly total expenditure by the household Patient’ Education: Illiterate patients are more likely to face CHE. Household’s Economic Status: The odds of facing CHE decreased as the household economic level increased. For example, the households in the first quintile were 7 fold more likely to face CHE compared to the households in the fifth quintile. Patient Supplementary Insurance Status: Households in which the patient did not have supplementary insurance were 44% more likely to pay for CHE compared to households with supplementary insurance. Type of Special Disease: Households having MS or renal replacement patients were respectively 2.1 and 1.4 times more likely to face CHE compared to households with a dialysis patient. This difference was not significant for kidney transplant patients. Family Member with a Special Disease: Households having more than 1 member with special disease were 5.5 times more likely to face CHE compared to those having only 1 member with special disease. Patient Residence: Living in rural areas increased the chance of facing CHE by 90%, but this was not statistically significant. Frequency of Using Inpatient Services: The possibility of facing CHE increased by 70% per any increase in the use of inpatient services by households. Use of Dental Care: The household use of dental care for the last 30 days increased the likelihood of facing CHE up to 2.3 times. Use of Rehabilitation Services: The Household use of rehabilitation services for the last 30 days increased the possibility of facing CHE up to 2.3 times. The results of Hosmer–Lemeshow test (p= 0.276) verified the accuracy of the model.

Discussion

Based on the definition of CHE by WHO, the results of our study revealed that 18.2% of the households with at least 1 dialysis, renal replacement, and MS patient had faced CHE. These findings indicated that merely having basic health insurance does not necessarily protect such households against CHE. Long period of illness and high costs of treatment and disability increase the possibility of facing CHE among these households. Moreover, intersectoral collaboration is necessary to provide more financial protection for these households and improve economic status, reinforce basic health insurance package, and exempt them from paying some of the health expenditures. According to the results of an Indian study in 2013, 82% of the people, who had renal replacement, experienced financial crisis during their treatment period. This crisis was reported to be highly severe for 54% of the studied group (9). Furthermore, Delavari et al. found that 67.9% of the households with a cancer patient had faced CHE in 2014 in Iran (7). Our study results revealed that household economic status was one of the effective factors on probability of facing CHE. Households with lower economic levels were more likely to have CHE. However, other national and foreign studies have shown a reverse relationship between household economic status and possibility of having CHE (6, 8, 33). Results of our study indicated that households with an MS, dialysis, or renal replacement patient had, respectively, paid 44.1, 35 and 36.4 US$, on average, for health services per month. Based on a national study in 2011, the average annual direct and indirect expenditures for a multiple sclerosis patient were estimated to be US$ 24 475 (18). In India, the average direct and indirect expenditures for renal replacement in public hospitals were US$7781 and US$3862, respectively. Additionally, 62% of the studied group lived below poverty line and 46% had sold their properties to afford a part of their renal replacement costs (9). Moreover, our study indicated that households, which had multiple family members with special diseases, were almost 5.5 times more likely to face CHE compared to those with only 1 patient. The former households had paid more medical expenditures. Based on a national study, households that had a disabled member at home were more likely to pay for CHE (8). Somkotra et al. concluded that presence of a chronically ill or disabled patient in the household is the main factor for facing CHE (35). According to the results of the present study, households in which patients did not have supplementary insurance were 44% more likely to pay for CHE compared to those with supplementary insurance. As Kavosi et al. showed in their study, households whose heads were not covered by supplementary insurance had 75% more chance of facing CHE compared to those who had supplementary insurance (8). In Iran, nationally produced medicines for patients with special diseases are provided free of charge; the costs for these diseases are financed by MOHME. However, deductible and the price difference between national and foreign medicines are paid by patients. Supplementary insurance covers these deductibles and price differences in Iran. These insurances are private and voluntarily, and most families can’t afford them. In Thailand, costs of dialysis treatments and chemotherapies, which were not covered by insurance companies, have had CHE for households after the implementation of UHC (36). In addition, our findings revealed that households with an MS or renal replacement patient were more likely to have CHE than households with dialysis patients. Patients are not asked to pay for dialysis treatment in Iranian hospitals. Moreover, the official price of kidney in Iran is 15 million Iranian Tomans (equivalent to US$5000); MOHME and insurance companies do not participate in paying this cost, and it is paid either by the patient or charity organizations (37). Furthermore, patients with special diseases do not pay anything if hospitalized in Iranian public hospitals. The price of foreign medicines for MS patients is very high in Iran and patients without supplementary insurance have to pay high costs for these medicines. According to our study, illiteracy increases the possibility of facing CHE. This is due to the fact that illiterate patients have weaker occupational and economic conditions, so they spend more of their financial capacity to pay for health expenditures. As pointed out by Fazaeli et al., education level is one of the main determinants for facing CHE (38). Furthermore, an Indian study showed that educational dropout and unemployment were the main threats for people who had renal replacement (9). Additionally, rural residence increases the chance of facing CHE; this finding has also been confirmed by other studies (4,8,38). This disparity is due to the lower income of rural residents, as well as their high indirect costs to access health services. Households that had used dental and rehabilitation services were 2.3 times more likely to face CHE compared to those that had not used these services. This finding was also supported by Kavosi et al. (8). Most of the dental and rehabilitation services are not covered by basic health insurance companies and patients should afford these costs. However, MS patients can use free physiotherapy services up to 80 sessions. Overall, supplementary insurances reimburse dental and rehabilitation services up to a certain level. It is necessary to cover these services to provide more financial protection for the families with patients suffering from special diseases. Moreover, households that had used inpatient services more frequently were more likely to experience CHE. Despite the implementation of HSEP and the dramatic decrease in the share of hospitalized patients to 3% and 6% of hospital bills (6), it is possible for these 3% to 6% deductibles to turn into CHE due to the households’ increased use of inpatient services. Because these patients usually lose their jobs either permanently or temporally, the “capacity to pay” of these households is very small. Exempting these households from paying for inpatient services seems vital to reduce their CHE and protect them more. National and foreign studies have confirmed the relationship between using health services and experiencing CHE (4,8).

Conclusion

Despite the fact that a year has been passed from the implementation of HSEP, the percentage of CHE is still high among households with special patients. Undoubtedly, one of the reasons for this lies in the specific conditions of these patients such as the long period of their illness and disability. However, more researches should be conducted to uncover the effects of HSEP on CHE in the long- term. Based on our results, it is important to increase the depth and coverage of basic health insurances and consider more cost-sharing exemption to protect these households more. Additionally, intersectoral policies should be improved to enhance their economic status.

Limitations

This study was conducted in Kurdistan province, located at the West of Iran, thus, the findings of this study might not be a representative picture of CHE status among households with members suffering from special diseases in Iran after implementation of HSEP. Furthermore, there was a possibility of over or under-reporting of the expenditures along with the recall bias of the participants. In addition, in this study, the items of money saving and borrowing were not considered for estimating the CHE.

Acknowledgments

We would like to thank the Social Determinants of Health Research Center as well as Special Disease Center of Treatment Deputy of Kurdistan University of Medical Sciences for their sincere cooperation. This article has been based on a research project financially supported and approved by the research Deputy of Kurdistan University of Medical Sciences (letter No. 94/104).

Conflict of Interests

The authors declare that they have no competing interests.
  21 in total

1.  Catastrophic payments for health care in Asia.

Authors:  Eddy van Doorslaer; Owen O'Donnell; Ravindra P Rannan-Eliya; Aparnaa Somanathan; Shiva Raj Adhikari; Charu C Garg; Deni Harbianto; Alejandro N Herrin; Mohammed Nazmul Huq; Shamsia Ibragimova; Anup Karan; Tae-Jin Lee; Gabriel M Leung; Jui-Fen Rachel Lu; Chiu Wan Ng; Badri Raj Pande; Rachel Racelis; Sihai Tao; Keith Tin; Kanjana Tisayaticom; Laksono Trisnantoro; Chitpranee Vasavid; Yuxin Zhao
Journal:  Health Econ       Date:  2007-11       Impact factor: 3.046

2.  Household financial contribution to the health System in Shiraz, Iran in 2012.

Authors:  Zahra Kavosi; Ali Keshtkaran; Ramin Hayati; Ramin Ravangard; Mohammad Khammarnia
Journal:  Int J Health Policy Manag       Date:  2014-09-17

3.  Factors affecting catastrophic health expenditure and impoverishment from medical expenses in China: policy implications of universal health insurance.

Authors:  Ye Li; Qunhong Wu; Ling Xu; David Legge; Yanhua Hao; Lijun Gao; Ning Ning; Gang Wan
Journal:  Bull World Health Organ       Date:  2012-06-13       Impact factor: 9.408

4.  [The quest for universal health coverage: achieving social protection for all in Mexico].

Authors:  Felicia Marie Knaul; Eduardo González-Pier; Octavio Gómez-Dantés; David García-Junco; Héctor Arreola-Ornelas; Mariana Barraza-Lloréns; Rosa Sandoval; Francisco Caballero; Mauricio Hernández-Ávila; Mercedes Juan; David Kershenobich; Gustavo Nigenda; Enrique Ruelas; Jaime Sepúlveda; Roberto Tapia; Guillermo Soberón; Salomón Chertorivski; Julio Frenk
Journal:  Salud Publica Mex       Date:  2013-04

5.  Changing epidemiology of end-stage renal disease in last 10 years in Iran.

Authors:  Mohammad Aghighi; Mitra Mahdavi-Mazdeh; Mahnaz Zamyadi; Alireza Heidary Rouchi; Hamid Rajolani; Shahram Nourozi
Journal:  Iran J Kidney Dis       Date:  2009-10       Impact factor: 0.892

6.  Estimating the financial cost of chronic kidney disease to the NHS in England.

Authors:  Marion Kerr; Benjamin Bray; James Medcalf; Donal J O'Donoghue; Beverley Matthews
Journal:  Nephrol Dial Transplant       Date:  2012-08-05       Impact factor: 5.992

7.  A study on the direct and indirect costs of multiple sclerosis based on expanded disability status scale score in khuzestan, iran.

Authors:  Amin Torabipour; Zahra Ahmadi Asl; Nastaran Majdinasab; Roya Ghasemzadeh; Hamed Tabesh; Mohammad Arab
Journal:  Int J Prev Med       Date:  2014-09

8.  An assessment of progress towards universal health coverage in Brazil, Russia, India, China, and South Africa (BRICS).

Authors:  Robert Marten; Diane McIntyre; Claudia Travassos; Sergey Shishkin; Wang Longde; Srinath Reddy; Jeanette Vega
Journal:  Lancet       Date:  2014-04-30       Impact factor: 79.321

9.  Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability.

Authors:  Virginia Casado; Sergio Martínez-Yélamos; Antonio Martínez-Yélamos; Olga Carmona; Lucia Alonso; Lucia Romero; Esther Moral; Laura Gubieras; Txomin Arbizu
Journal:  BMC Health Serv Res       Date:  2006-11-01       Impact factor: 2.655

10.  Kidney transplantation is associated with catastrophic out of pocket expenditure in India.

Authors:  Raja Ramachandran; Vivekanand Jha
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

View more
  5 in total

1.  Cost-effectiveness analysis of rituximab versus natalizumab in patients with relapsing remitting multiple sclerosis.

Authors:  Mehdi Rezaee; Mohammad Hossein Morowvat; Maryam Poursadeghfard; Armin Radgoudarzi; Khosro Keshavarz
Journal:  BMC Health Serv Res       Date:  2022-01-28       Impact factor: 2.655

2.  Incidence of Catastrophic Health Expenditure and Its Determinants in Cancer Patients: A Systematic Review and Meta-analysis.

Authors:  Leila Doshmangir; Edris Hasanpoor; Gerard Joseph Abou Jaoude; Behzad Eshtiagh; Hassan Haghparast-Bidgoli
Journal:  Appl Health Econ Health Policy       Date:  2021-07-28       Impact factor: 2.561

3.  Catastrophic Health Expenditure among Chronic Patients Attending Dessie Referral Hospital, Northeast Ethiopia.

Authors:  Yohannes Shumet; Solomon Ahmed Mohammed; Mesfin Haile Kahissay; Birhanu Demeke
Journal:  Clinicoecon Outcomes Res       Date:  2021-02-03

4.  The catastrophic out-of-pocket health expenditure of multiple sclerosis patients in Iran.

Authors:  Farid Gharibi; Ali Imani; Koustuv Dalal
Journal:  BMC Health Serv Res       Date:  2021-03-20       Impact factor: 2.655

Review 5.  Determinants of catastrophic health expenditures in Iran: a systematic review and meta-analysis.

Authors:  Leila Doshmangir; Mahmood Yousefi; Edris Hasanpoor; Behzad Eshtiagh; Hassan Haghparast-Bidgoli
Journal:  Cost Eff Resour Alloc       Date:  2020-05-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.